Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
The inflamed liver in chronic hepatitis B virus (HBV) infection (CHB) is characterized by a large influx of non–virus-specific CD8 T cells. Little is known about the functional capacity of these lymphocytes, which could provide insights into mechanisms of failure of viral control and liver damage in this setting. We compared the effector function of total circulating and intrahepatic CD8 T cells in CHB patients and healthy donors. We demonstrated that CD8 T cells from CHB patients, regardless of their antigen specificity, were impaired in their ability to produce interleukin-2 and proliferate upon TCR-dependent stimulation. In contrast, these CD8 T cells had preserved production of the proinflammatory cytokines interferon-γ and tumor necrosis factor-α. This aberrant functional profile was partially attributable to down-regulation of the proximal T cell receptor signaling molecule CD3ζ, and could be corrected in vitro by transfection of CD3ζ or replenishment of the amino acid arginine required for its expression. We provide evidence for depletion of arginine in the inflamed hepatic microenvironment as a potential mechanism for these defects in global CD8 T cell signaling and function. These data imply that polarized CD8 T cells within the HBV-infected liver may impede proliferative antiviral effector function, while contributing to the proinflammatory cytokine environment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 4. CD3ζ is down-regulated in both peripheral and intrahepatic CD8 from patients with chronic HBV. PBMCs or intrahepatic lymphocytes isolated from biopsy tissue were surface stained for CD3ε and CD8, fixed, permeabilized, and stained for intracellular CD3ζ or its isotype. A tight lymphocyte gate and secondary gate over CD3ε+CD8 cells has been applied. A marker was applied at the edge of the isotype control (solid black line) and the proportion of CD8 to the right of this line represented the CD3ζ+ fraction. (a) Representative flow cytometric histogram illustrating CD3ζ expression (as a percentage and as mean fluorescence intensity [MFI]) for a chronic HBV-infected patient with high viral load (>106 IU/ml; dashed line) and a healthy control (gray). (b) CD3ζ levels, shown as both MFI and percentage of CD3ζ+ in the total CD8 are shown against viral load (top), and percentage values are further broken down by HBeAg status and ALT (bottom). (c) Histogram to illustrate differential expression of CD3ζ by peripheral (dark gray) and intrahepatic (light gray) CD8 from a CHB donor (dotted line, isotype). (d) The difference in CD3ζ expression between intrahepatic and peripheral CD8 is plotted for each patient with HBV/non-HBV–related liver disease.](https://figures.cochat.ai/paper-figures/7ff43f33481548d4a97e76a0dcd07fd0/functional-skewing-of-the-global-cd8-t-cell-population-in-chronic-hepatitis-b-figure-4.jpg)




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effector and memory T-cell differentiation: implications for vaccine development
Kaech, S. M., Wherry, E. J., & Ahmed, R. (2002) · Nature Reviews Immunology · doi:10.1038/nri778 · Cited by 1,865
Regulation of immune responses by L-arginine metabolism
Bronte, V., & Zanovello, P. (2005) · Nature Reviews Immunology · doi:10.1038/nri1668 · Cited by 1,775
Wherry, E. J., Blattman, J. N., Murali-Krishna, K., van der Most, R., & Ahmed, R. (2003) · Journal of Virology · doi:10.1128/jvi.77.8.4911-4927.2003 · Cited by 1,610
Phenotypic and functional separation of memory and effector human CD8+ T cells
Hamann, D., Baars, P. A., Rep, M. H. G., Hooibrink, B., Kerkhof-Garde, S. R., Klein, M. R., & Lier, R. A. W. V. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.9.1407 · Cited by 1,366
Frumento, G., Rotondo, R., Tonetti, M., Damonte, G., Benatti, U., & Ferrara, G. B. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020121 · Cited by 1,133
Intracellular Inactivation of the Hepatitis B Virus by Cytotoxic T Lymphocytes
Guidotti, L. G., Ishikawa, T., Hobbs, M. V., Matzke, B., Schreiber, R., & Chisari, F. V. (1996) · Immunity · doi:10.1016/s1074-7613(00)80295-2 · Cited by 1,083
Fallarino, F., Grohmann, U., You, S., McGrath, B. C., Cavener, D. R., Vacca, C., Orabona, C., Bianchi, R., Belladonna, M. L., Volpi, C., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.11.6752 · Cited by 1,047
Thimme, R., Wieland, S., Steiger, C., Ghrayeb, J., Reimann, K. A., Purcell, R. H., & Chisari, F. V. (2003) · Journal of Virology · doi:10.1128/jvi.77.1.68-76.2003 · Cited by 979
L-arginine availability regulates T-lymphocyte cell-cycle progression.
Rodriguez, P. C., Quiceno, D. G., & Ochoa, A. C. (2007) · Blood · doi:10.1182/blood-2006-06-031856 · Cited by 926
Characterization of Hepatitis B Virus (HBV)-Specific T-Cell Dysfunction in Chronic HBV Infection
Boni, C., Fisicaro, P., Valdatta, C., Amadei, B., Di Vincenzo, P., Giuberti, T., Laccabue, D., Zerbini, A., Cavalli, A., Missale, G., et al. (2007) · Journal of Virology · doi:10.1128/jvi.02844-06 · Cited by 920
Self-citation
Research works printed but not linked: 3
- 1993, Cancer Res., 53, 5610
- 1991, Transplant. Proc., 23, 1436
- 1995, Hepatology., 21, 1585
Cited by
Items 201–263 of 263
Jespersen, J. M., Avanesyan, L., Publicover, J., Carey, N. D., Patel, R. K., Edwards, A. W., Stenske, S., Shin, J., Li, J., Simone, M., et al. (2026) · Science Translational Medicine · doi:10.1126/scitranslmed.adx1523 · Cited by 4
Li, J., Niu, W., Zheng, Q., Meng, G., Chen, X., Zhang, M., Deng, G., Mao, Q., & Wang, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.640335 · Cited by 4
“alanine aminotransferase, units/L ND 26 (12-42) 525.”
Darmadi, D., Lindarto, D., Siregar, J., Widyawati, T., Rusda, M., Amin, M. M., Yusuf, F., Eyanoer, P. C., Lubis, M., & Rey, I. (2022) · F1000Research · doi:10.12688/f1000research.128116.2 · Cited by 3
Hepatitis B Virus Immunopathogenesis
Iannacone, M., & Guidotti, L. G. (2015) · Molecular and translational medicine · doi:10.1007/978-3-319-22330-8_4 · Cited by 3
“, arginase) possessing immunosuppressive potential [ 60 – 62 ].”
Jin, J., Liu, Y., Xu, X., Wang, Z., & Niu, J. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06918-7 · Cited by 3
Wu, D., & Ning, Q. (2017) · Springer eBooks · doi:10.1007/978-981-10-4843-2_12 · Cited by 2
Current research insights into the role of CTLA ‐4 in hepatitis B virus ( HBV ) infection
Gu, Q., Yin, S., Tong, X., Rui, F., Zhu, Y., Ma, X., Huang, R., Wu, C., & Li, J. (2024) · Journal of Viral Hepatitis · doi:10.1111/jvh.13958 · Cited by 2
Management of patients coinfected with HBV and HCV
Potthoff, A., Jaroszewicz, J., Manns, M. P., & Wedemeyer, H. H. (2010) · Hot Topics in Viral Hepatitis · doi:10.4147/htv-101707 · Cited by 2
Régulation de l’immunopathogenèse du virus de l’hépatite B par des cellules myéloïdes suppressives
Faure‐Dupuy, S., & Lucifora, J. (2016) · médecine/sciences · doi:10.1051/medsci/20163203004 · Cited by 2
MOLECULAR BIOLOGY OF HEPATITIS B VIRUS AND IMMUNOPATHOGENESIS OF CHRONIC VIRAL HEPATITIS B
Балмасова, И. П., Sepiashvili, R. I., & Малова, Е. С. (2016) · Journal of microbiology epidemiology immunobiology · doi:10.36233/0372-9311-2016-2-119-126 · Cited by 2
Kim, H. S., Park, E., & Lee, C. (2019) · Precision and Future Medicine · doi:10.23838/pfm.2018.00135 · Cited by 2
“Dysfunctional T cell responses are also observed in chronic HBV- or HCV-infected patients [31].”
BackgroundVirology and Pathogenesis of Hepatitis B
Bertoletti, A., Lucifora, J., & Zoulim, F. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-37591-7.00031-8 · Cited by 4
Self-citationRazafimahatratra, S. L., Andriatefy, O. H., Mioramalala, D. J. N., Tsatoromila, F. A. M., Randrianarisaona, F., Dussart, P., & Schoenhals, M. J. (2023) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2023.11.020 · Cited by 2
Bertoletti, A., & Huang, H. (2020) · Springer eBooks · doi:10.1007/978-3-030-51709-0_16 · Cited by 1
Self-citationEzer, B., Çiftci, H. S., Uğraklı, S., Iyısoy, M. S., & Özdemir, M. (2025) · Viruses · doi:10.3390/v17101352 · Cited by 1
“This is one of the main mechanisms of viral persistence [4].”
He, S., Tan, A. T., & Bertoletti, A. (2025) · Seminars in Immunology · doi:10.1016/j.smim.2025.102004 · Cited by 1
Self-citationHuang, D., Sansas, B., Jiang, J., Gong, Q., Jin, G.-D., Calais, V., Yu, D., Zhu, M. Y., Wei, D., Zhang, D. H., et al. (2017) · Journal of Viral Hepatitis · doi:10.1111/jvh.12791 · Cited by 1
Knolle, P. A. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0881-3.00009-7 · Cited by 1
Bakarozi, M., Mavropoulos, Α., Bogdanos, D. P., Dalekos, G. Ν., & Rigopoulou, E. I. (2019) · Journal of Viral Hepatitis · doi:10.1111/jvh.13209 · Cited by 1
Stephan, A.-S., Kosinska, A. D., Mück-Häusl, M., Muschaweckh, A., Jäger, C., Röder, N., Heikenwälder, M. F., Dembek, C. J., & Protzer, U. (2023) · Vaccines · doi:10.3390/vaccines11020245 · Cited by 1
Immune Mechanisms of Viral Clearance and Disease Pathogenesis During Viral Hepatitis
Ferrari, C. I., & Mondelli, M. U. (2009) · Wiley eBooks · doi:10.1002/9780470747919.ch51 · Cited by 3
Liu, M. (2011) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 1
Maponga, T. G. (2016) · SUNScholar (Stellenbosch University) · Cited by 1
Pig interorgan balance studies in health and disease
Have, G. A. M. T. (2017) · Research Publications (Maastricht University) · doi:10.26481/dis.20170913gth · Cited by 2
Constraints on the CD8 T cell response in chronic HBV infection
Das, A. (2009) · OpenGrey (Institut de l'Information Scientifique et Technique)
Self-citationMartinet, J. (2012) · theses.fr (ABES) · doi:10.70675/f6f25ebfz12b8z4f3ezbd06z32a56200dbca · Cited by 1
Kosinska, A. D. (2011) · DuEPublico (University of Duisburg-Essen)
Megha, U., Miquel, J., Benito, S., & Larrubi, J.-R. (2011) · InTech eBooks · doi:10.5772/25832
Kutscher, S. (2010) · Elektronische Hochschulschriften der LMU München (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.11730
Potentiel immuno-thérapeutique des pDCs dans l'hépatite B chronique
Martinet, J. (2011) · HAL
Ostéomyélite cryptococcique chez un patient atteint d’hépatite B chronique
Delaval, A., Porcheret, H., & Jacquier, H. (2012) · Immuno-analyse & Biologie Spécialisée · doi:10.1016/j.immbio.2012.07.025
Yuguo, S., Lei, X., & Shengli, B. (2011) · International Conference on Human Health and Biomedical Engineering · doi:10.1109/hhbe.2011.6027968
“shown that the clonal expansion for the hepatitis B virus antigen mainly occurs in CD8(+) T lymphocytes rather than CD4(+) T lymphocytes [7].”
BackgroundRamachandran, P., Pellicoro, A., Vernon, M. A., Boulter, L., Aucott, R. L., Forbes, S. J., & Iredale, J. P. (2011) · Gut · doi:10.1136/gutjnl-2011-300857b.14
OP15 Discovery of new liver fibrosis markers in hepatitis C patients using proteomics
Gangadharan, B., Bapat, M., Rossa, J., Antrobus, R., Chittenden, D., Kampa, B., Barnes, E. J., Dwek, R. A., & Zitzmann, N. (2011) · Gut · doi:10.1136/gutjnl-2011-300857b.15
Osuna-Gutierrez, C. E. (2012) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Griffiths, S. (2011) · UCL Discovery (University College London)
Hepatitis B and the Immune System
Chang, K. (2010) · Current Hepatology Reports · doi:10.1007/s11901-010-0051-5
“Conversely, the inflamed liver microenvironment may induce a global functional skewing of CD8 T cells [48].”
BackgroundWang, S. M. (2010) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/42459
“Wang Suk Mei Dec 2010 III Table of Contents Acknowledgements I Table of Contents III List of Tables VIII List of Figures X List of Abbreviations XII Publications XIV Summary XV CHAPTER 1 Introduction and Literature Review 1 1.1 The Liver 1 1.1.1 Microstructure and vascular supply 1 1.1.2 Segmental anatomy 2 1.1.3 Cell…”
BackgroundInfluentialMarrinan, E., Walker, L. J., Barnes, E. J., & Klenerman, P. (2011) · Gut · doi:10.1136/gutjnl-2011-300857b.13
Li, F., Wei, H., Wei, H., Gao, Y., Xu, L., Yin, W., Sun, R., & Tian, Z. (2013)
Translational Medicine in Hepatitis B Virus: What Can We Learn from Clinical Samples?
Bertoletti, A., & Zoulim, F. (2015) · Molecular and translational medicine · doi:10.1007/978-3-319-22330-8_8
Self-citationRegulation of Metalloproteinase-dependent Ectodomain Shedding in Cytokine Biology and Inflammation
Murthy, A. (2012) · Library and Archives Canada (Government of Canada)
Cheng, Y. (2018) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/73169
Zhou, J., Kong, C., Ban, B., Dong, H., & Jin, C. (2018) · Annals of Hepatology · doi:10.5604/01.3001.0010.8636
Immunopathogenesis of Hepatitis B Virus Infection
Chua, C., Salimzadeh, L., & Gehring, A. J. (2021) · Springer eBooks · doi:10.1007/978-981-16-3615-8_4
Immunoregulation by HCV-generated Myeloid Suppressor Cells
Yergin, C. G. (2016) · doi:10.18130/v39z95 · Cited by 1
Zilio, S. (2012) · Padua Research Archive (University of Padova)
Wu, D., & Ning, Q. (2021) · Springer eBooks · doi:10.1007/978-981-16-3615-8_14
Plant bioactives in immune modulation and their role in antiaging
Aydin, Y., Dikbasan, Y. U., & Yılmaz, B. O. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90581-7.00010-4
Occult Hepatitis B Virus: Implications in Endemic Region like Nigeria.
Adeniyi, A. A., Adeniyi, O. A., Kemiki, O. A., Adetunji, S. O., Olamiju, P. O., Aiyegbokiki, D. C., Akinjinmi, A. A., Akinola, O. J., Eze, C. T., & OYERINDE, J. F. (2022) · Clinical Medicine And Health Research Journal · doi:10.18535/cmhrj.v2i6.93
“It is usually lifelong and is believed to be as a result of dysfunction HBV-specific T-cell from exhausted T-cell thereby affecting the normal function of the cells to fight infection (Das et al., 2008).”
BackgroundSuivi de la réponse immunitaire adaptative spécifique d’un antigène exprimé dans le foie
Cardon, A. (2022) · theses.fr (ABES) · doi:10.70675/c5215f01z7c40z44baz8356z470ba40f9128
Khanam, A., Ghosh, A., Chua, J. V., & Kottilil, S. (2024) · Figshare · doi:10.6084/m9.figshare.26583954
Hess, L. (2021) · University of Regensburg Publication Server (University of Regensburg) · doi:10.5283/epub.45469
Einfluss von Leberschaden auf die Qualität der antiviralen Immunantwort in der Leber
König, V. (2020) · mediaTUM (Technical University of Munich)
The Hunt for Immune Biomarkers during Chronic Hepatitis B Infection
Chua, C. (2023) · TSpace (University of Toronto)
Gouilly, J. (2018) · theses.fr (ABES) · doi:10.70675/e8f87c4fz838ez4254zafdazcc06fa9ee7ea
Labarthe, L. (2020) · theses.fr (ABES) · doi:10.70675/8e0a6f66ze74dz497cz89b5z17639f9eff02 · Cited by 2
Akbar, S. M. F., Mahtab, M. A., Rahim, M. A., Noor-E-Alam, S. M., Mahtab, M., Moben, A. L., Begum, R., Das, D. C., Gerardo, G., Yoshida, O., et al. (2026) · Vaccines · doi:10.3390/vaccines14090821
“Chronic HBV infection induces functional exhaustion of HBV-specific T cells, and although NUCs suppress viral replication, they rarely restore effective immunity [39,40].”
Metadata
- Authors
- Das, A., Hoare, M., Davies, N., Lopes, A. R., Dunn, C., Kennedy, P. T. F., Alexander, G., Finney, H., Lawson, A., Plunkett, F. J., Bertoletti, A., Akbar, A. N., & Maini, M. K.
- Affiliations
- 1Division of Infection and Immunity
- Addenbrooke's Hospital (GB)
- 2Institute of Hepatology
- Cell Biotech (South Korea) (KR)
- Agency for Science, Technology and Research (SG)
- University College London (GB)
- ORCID
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2008-08-11
- Volume
- 205
- Issue
- 9
- Pages
- 2111-2124
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2526205
- OpenAlex
- W2020211914
- Cited by
- 256
- References
- 60
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 9 · 2023: 12 · 2022: 9 · 2021: 16 · 2020: 14 · 2019: 16 · 2018: 13 · 2017: 16 · 2016: 11 · 2015: 15 · 2014: 20 · 2013: 19 · 2012: 25
- FWCI
- 13.36
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- University College London
- Medical Research Council
- Topics
- Health Sciences › Medicine › Epidemiology › Hepatitis B Virus Studies
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- chronic hepatitis B, CD8+ T cells, T cell dysfunction, T cell receptor signaling, CD3zeta, arginine deprivation, IL-2 production, T cell proliferation, interferon-gamma, TNF-α, liver inflammation, intrahepatic T cells
- MeSH terms
- Adult, Aged, Female, Hepatitis B virus, Humans, Interferon-gamma, Interleukin-2, Male, Middle Aged, Models, Biological, Tumor Necrosis Factor-alpha, HLA-A2 Antigen, CD8-Positive T-Lymphocytes, Viral Load, Hepatitis B, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.